Home
PLUR
PLUR News

Latest Pluri Inc. (PLUR) News on November 18, 2024

Pluri First Quarter 2025 Earnings: US$1.08 loss per share (vs US$0.96 loss in 1Q 2024)

Simply Wall St.

3 days ago

Pluri First Quarter 2025 Earnings: US$1.08 loss per share (vs US$0.96 loss in 1Q 2024)

Associated Press Finance

5 days ago

Pluri: Fiscal Q1 Earnings Snapshot

ACCESSWIRE

5 days ago

Pluri Inc. to Present at November 21st Virtual Investor Summit Microcap Event

BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing

PR Newswire

7 days ago

BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing

Pluri Collaborates with Bar-Ilan University to Advance Cancer Immunotherapy for Solid Tumors, Supported by Israel Innovation Authority

GlobeNewswire

21 days ago

Pluri Collaborates with Bar-Ilan University to Advance Cancer Immunotherapy for Solid Tumors, Supported by Israel Innovation Authority

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

ACCESSWIRE

2 months ago

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

MT Newswires

4 months ago

Pluri Shares Rise After Manufacturing Accord With Kadimastem Set

Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates

GlobeNewswire

4 months ago

Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates

Pluri Announces €1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply

GlobeNewswire

4 months ago

Pluri Announces €1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply

MT Newswires

5 months ago

Pluri Appoints Liat Zalts as CFO

MT Newswires

5 months ago

Sector Update: Consumer

MT Newswires

5 months ago

Pluri's Ever After Foods Subsidiary Gets $10 Million Investment; Shares Rise

Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges

GlobeNewswire

5 months ago

Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges

U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri’s PLX-R18 Acute Radiation Syndrome Contract

GlobeNewswire

5 months ago

U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri’s PLX-R18 Acute Radiation Syndrome Contract

Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale

GlobeNewswire

6 months ago

Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale

Pluri Third Quarter 2024 Earnings: US$1.01 loss per share (vs US$1.53 loss in 3Q 2023)

Simply Wall St.

6 months ago

Pluri Third Quarter 2024 Earnings: US$1.01 loss per share (vs US$1.53 loss in 3Q 2023)

Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment

GlobeNewswire

7 months ago

Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment

Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method

GlobeNewswire

7 months ago

Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method

Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences

GlobeNewswire

8 months ago

Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences

Pluri Inc. Announces 1-for-8 Reverse Share Split

GlobeNewswire

8 months ago

Pluri Inc. Announces 1-for-8 Reverse Share Split

Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report

GlobeNewswire

8 months ago

Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report

Engage with Pluri's Talent: Exciting Conference Appearances Ahead

GlobeNewswire

8 months ago

Engage with Pluri's Talent: Exciting Conference Appearances Ahead

Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing

GlobeNewswire

8 months ago

Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing

Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation

GlobeNewswire

8 months ago

Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation

Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board

GlobeNewswire

8 months ago

Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board

Pluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals

GlobeNewswire

9 months ago

Pluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals

Pluri Second Quarter 2024 Earnings: US$0.12 loss per share (vs US$0.24 loss in 2Q 2023)

Simply Wall St.

9 months ago

Pluri Second Quarter 2024 Earnings: US$0.12 loss per share (vs US$0.24 loss in 2Q 2023)

Associated Press Finance

9 months ago

Pluri: Fiscal Q2 Earnings Snapshot

Third Coast Bancshares, Inc. (NASDAQ:TCBX) Q4 2023 Earnings Call Transcript

Insider Monkey

10 months ago

Third Coast Bancshares, Inc. (NASDAQ:TCBX) Q4 2023 Earnings Call Transcript

Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis

GlobeNewswire

10 months ago

Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis

Gilead Sciences, Citi, Digital World Acquisition: Top Stocks

Yahoo Finance Video

10 months ago

Gilead Sciences, Citi, Digital World Acquisition: Top Stocks

Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

GlobeNewswire

10 months ago

Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17

GlobeNewswire

10 months ago

ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17

ASHFORD HOSPITALITY TRUST ANNOUNCES PRELIMINARY FOURTH QUARTER 2023 RESULTS

PR Newswire

10 months ago

ASHFORD HOSPITALITY TRUST ANNOUNCES PRELIMINARY FOURTH QUARTER 2023 RESULTS

Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing Organization

GlobeNewswire

10 months ago

Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing Organization

Tiptree Inc. Announces Tax Treatment of 2023 Common Stock Distributions

Business Wire

10 months ago

Tiptree Inc. Announces Tax Treatment of 2023 Common Stock Distributions

Resources Connection, Inc. (NASDAQ:RGP) Q2 2024 Earnings Call Transcript

Insider Monkey

10 months ago

Resources Connection, Inc. (NASDAQ:RGP) Q2 2024 Earnings Call Transcript

AdTheorent Partners with Jounce Media to Verify Removal of Made for Advertising (MFA) Properties from Its Campaigns

PR Newswire

10 months ago

AdTheorent Partners with Jounce Media to Verify Removal of Made for Advertising (MFA) Properties from Its Campaigns

Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine Addiction

GlobeNewswire

a year ago

Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine Addiction

Reorganization of Virtus Stone Harbor Closed-End Funds Completed

Business Wire

a year ago

Reorganization of Virtus Stone Harbor Closed-End Funds Completed

Zentek and 1Click Heating and Cooling Sign Distribution Agreement

ACCESSWIRE

a year ago

Zentek and 1Click Heating and Cooling Sign Distribution Agreement

Fathom Realty to raise agent fees in 2024 to boost earnings

HousingWire

a year ago

Fathom Realty to raise agent fees in 2024 to boost earnings

Sidoti Events, LLC's Virtual December Small-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

UCloudlink Group Inc. Sponsored ADR (UCL) Beats Q3 Earnings and Revenue Estimates

Zacks

a year ago

UCloudlink Group Inc. Sponsored ADR (UCL) Beats Q3 Earnings and Revenue Estimates

GlobeNewswire

a year ago

UCLOUDLINK GROUP INC. Announces Unaudited Third Quarter 2023 Financial Results

Associated Press Finance

a year ago

Pluri: Fiscal Q1 Earnings Snapshot

MISTRAS Group to Participate in Sidoti Micro Cap Virtual Conference on November 15-16, 2023

GlobeNewswire

a year ago

MISTRAS Group to Participate in Sidoti Micro Cap Virtual Conference on November 15-16, 2023

GlobeNewswire

a year ago

UCLOUDLINK GROUP INC. to Report Third Quarter 2023 Financial Results on November 15, 2023

The one-year earnings decline is not helping Big 5 Sporting Goods' (NASDAQ:BGFV share price, as stock falls another 25% in past week

Simply Wall St.

a year ago

The one-year earnings decline is not helping Big 5 Sporting Goods' (NASDAQ:BGFV share price, as stock falls another 25% in past week

Share on Social Networks: